Cargando…
Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review
Dipeptidyl peptidase-4 inhibitors (DPP4Is) were introduced into the management of type 2 diabetes mellitus (T2DM) as they are insulinotropic and have no inherent risk of hypoglycemia and no effect on body weight. Currently, 11 drugs in this class are available for the management of diabetes. Althoug...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291938/ https://www.ncbi.nlm.nih.gov/pubmed/37378205 http://dx.doi.org/10.7759/cureus.39204 |